These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10514074)

  • 1. Dissociation between complement activation, integrin expression and neutropenia during hemodialysis.
    Rousseau Y; Carreno MP; Poignet JL; Kazatchkine MD; Haeffner-Cavaillon N
    Biomaterials; 1999 Oct; 20(20):1959-67. PubMed ID: 10514074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biocompatibility of dialysis membranes: effects of chronic complement activation.
    Hakim RM; Fearon DT; Lazarus JM
    Kidney Int; 1984 Aug; 26(2):194-200. PubMed ID: 6334194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hemodialysis on leukocyte adhesion receptor expression.
    Kaupke CJ; Zhang J; Cesario T; Yousefi S; Akeel N; Vaziri ND
    Am J Kidney Dis; 1996 Feb; 27(2):244-52. PubMed ID: 8659501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meltspun cellulose diacetate and polysulfone membranes have the same effect on complement activation and expression of leukocyte adhesion molecules and complement receptors.
    Dameche L; Brunet P; George F; André-Pinon S; Bernard D; Sampol J; Berland Y
    Nephrol Dial Transplant; 1995; 10 Suppl 10():33-8. PubMed ID: 8825430
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell activation and cellular-cellular interactions during hemodialysis: effect of dialyzer membrane.
    Sirolli V; Ballone E; Di Stante S; Amoroso L; Bonomini M
    Int J Artif Organs; 2002 Jun; 25(6):529-37. PubMed ID: 12117292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte activation and adhesion molecules during hemodialysis with cuprophane and a high-flux biocompatible membrane.
    Combe C; Pourtein M; de Précigout V; Baquey A; Morel D; Potaux L; Vincendeau P; Bézian JH; Aparicio M
    Am J Kidney Dis; 1994 Sep; 24(3):437-42. PubMed ID: 8079969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of hemodialysis with frequent use of cuprophan and polysulfone membranes on activation of complement in patients with chronic renal failure].
    Zukowska-Szczechowska E; Moczulski D; Grzeszczak W; Gosek K; Augustyn M; Staszewicz P
    Pol Arch Med Wewn; 1996 Nov; 96(5):458-68. PubMed ID: 9091856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increases in circulating level of platelet-activating factor lag behind transient neutropenia during hemodialysis with cuprophane membranes.
    Sakaguchi K; Morimoto S; Chen YH; Nakamoto Y; Ogihara T
    Nephron; 1991; 59(3):455-60. PubMed ID: 1758537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a bovine model to study the role of adhesion molecule CD11/CD18 in hemodialysis-induced neutropenia.
    Rabb H; Chandran PK; Arnaout MA; Kehrli ME
    Am J Kidney Dis; 2002 Mar; 39(3):587-93. PubMed ID: 11877578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of hemodialysis with cuprophane and polysulfone membranes on counts of leukocytes, granulocytes, monocytes, lymphocytes and lymphocyte subsets].
    Moczulski D; Zukowska-Szczechowska E; Grzeszczak W; Religa Z; Cichoń R; Szydłowska I
    Pol Arch Med Wewn; 1994 Nov; 92(5):400-7. PubMed ID: 7885988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biocompatibility of hemodialysis membranes: evaluation in an ovine model.
    Burhop KE; Johnson RJ; Simpson J; Chenoweth DE; Borgia J
    J Lab Clin Med; 1993 Feb; 121(2):276-93. PubMed ID: 8433041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukocyte, platelet and endothelial activation in patients with acute renal failure treated by intermittent hemodialysis.
    de Sá HM; Freitas LA; Alves VC; Garção MF; Rosa MA; Marques AA
    Am J Nephrol; 2001; 21(4):264-73. PubMed ID: 11509797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of granulocyte activation during hemodialysis with regional citrate anticoagulation: dissociation of complement activation and neutropenia from neutrophil degranulation.
    Böhler J; Schollmeyer P; Dressel B; Dobos G; Hörl WH
    J Am Soc Nephrol; 1996 Feb; 7(2):234-41. PubMed ID: 8785392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical sequelae of complement activation in hemodialysis.
    Hakim RM
    Clin Nephrol; 1986; 26 Suppl 1():S9-12. PubMed ID: 3829474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [C-reactive protein (CRP) as a marker of of hemodialysis biocompatibility].
    Szepietowski T; Krajewska M
    Polim Med; 1997; 27(1-2):47-59. PubMed ID: 9380601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo biocompatibility of substituted cellulose and synthetic membranes.
    Mandolfo S; Tetta C; David S; Gervasio R; Ognibene D; Wratten ML; Tessore E; Imbasciati E
    Int J Artif Organs; 1997 Nov; 20(11):603-9. PubMed ID: 9464869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary report on complement activating potential of polycarbonate membrane.
    Henderson LW; Chenoweth DE; Shinaberger JH; Miller J; Konstantin P
    Blood Purif; 1986; 4(1-3):74-81. PubMed ID: 3730164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the mechanisms of haemodialysis-induced neutropenia: a study with five new and re-used membranes.
    Heierli C; Markert M; Lambert PH; Kuwahara T; Wauters JP
    Nephrol Dial Transplant; 1988; 3(6):773-83. PubMed ID: 3147419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dialysis neutropenia: the role of the cytoskeleton.
    Tabor B; Geissler B; Odell R; Schmidt B; Blumenstein M; Schindhelm K
    Kidney Int; 1998 Mar; 53(3):783-9. PubMed ID: 9507227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.